AIL
IONS icon

AGF Investments LLC’s Ionis Pharmaceuticals IONS Stock Holding History

AGF Investments LLC’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,936
Closed -$534K – 468
2021
Q3 		$534K Sell
15,936
-1,353
-8% -$51K 0.05% 225
2021
Q2 		$690K Buy
+17,289
New +$677K 0.07% 75
2020
Q2 		– Sell
-14,827
Closed -$701K – 641
2020
Q1 		$701K Buy
+14,827
New +$826K 0.09% 177
2019
Q4 		– Sell
-128
Closed -$8K – 651
2019
Q3 		$8K Sell
128
-50
-28% -$3.26K ﹤0.01% 517
2019
Q2 		$11K Buy
+178
New +$12.6K ﹤0.01% 500
2017
Q4 		– Sell
-188
Closed -$10K – 784
2017
Q3 		$10K Hold
188
– – ﹤0.01% 526
2017
Q2 		$10K Buy
+188
New +$8.75K ﹤0.01% 503

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AGF Investments LLC's IONS Position: Q4 2021 in Review

AGF Investments LLC sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 15,936 shares — an estimated $534K sold.

AGF Investments LLC first reported a position in IONS in Q2 2017 and held it in 7 quarters. The position peaked at $701K in Q1 2020. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • AGF Investments LLC reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • AGF Investments LLC sold 15,936 Ionis Pharmaceuticals shares in Q4 2021, an estimated $534K.
  • AGF Investments LLC first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 7 quarters.
  • AGF Investments LLC's Ionis Pharmaceuticals position peaked at $701K in Q1 2020.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on AGF Investments LLC's 13F filing for Q4 2021, filed 1 Feb 2022.